Targeting the PRMT1 axis in cancer: from epigenetic plasticity to contextual therapeutic interventions
Protein arginine methyltransferase 1 (PRMT1), the predominant Type I arginine methyltransferase, is reported to play the key role in regulating cancer epigenetics. Its activity directs gene expression, chromatin structure and transcriptional activation by mediating asymmetric dimethylation of histon...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-07-01
|
| Серія: | Frontiers in Oncology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1841266/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|